CA2420327A1 - Dosage immunologique differentiel - Google Patents
Dosage immunologique differentiel Download PDFInfo
- Publication number
- CA2420327A1 CA2420327A1 CA002420327A CA2420327A CA2420327A1 CA 2420327 A1 CA2420327 A1 CA 2420327A1 CA 002420327 A CA002420327 A CA 002420327A CA 2420327 A CA2420327 A CA 2420327A CA 2420327 A1 CA2420327 A1 CA 2420327A1
- Authority
- CA
- Canada
- Prior art keywords
- analyte
- conjugate
- sample
- binding partner
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention porte sur des kits et sur des méthodes de dosage qui permettent de mesurer en général le taux d'un premier analyte dans un échantillon réduit par le taux d'un second analyte présent dans ce même échantillon. Selon une réalisation, on détermine le taux d'un premier analyte à partir d'une première source et on libère le premier analyte de l'échantillon d'une seconde source par colibération proportionnelle d'un second analyte. Le dosage identifie le taux du premier analyte libéré uniquement de la première source. Pour des analytes se trouvant dans des fluides biologiques, le dosage peut différencier les taux élevés d'un analyte spécifique à un état physiologique ou pathologique donné des taux élevés d'un analyte spécifique à l'état donné, ce qui permet d'obtenir des tests uniques utiles dans les diagnostics.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22753600P | 2000-08-24 | 2000-08-24 | |
| US60/227,536 | 2000-08-24 | ||
| US29249701P | 2001-05-21 | 2001-05-21 | |
| US60/292,497 | 2001-05-21 | ||
| US09/938,270 | 2001-08-23 | ||
| PCT/IB2001/001531 WO2002016943A2 (fr) | 2000-08-24 | 2001-08-24 | Dosage immunologique differentiel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2420327A1 true CA2420327A1 (fr) | 2002-02-28 |
Family
ID=26921525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002420327A Abandoned CA2420327A1 (fr) | 2000-08-24 | 2001-08-24 | Dosage immunologique differentiel |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001284317A1 (fr) |
| CA (1) | CA2420327A1 (fr) |
-
2001
- 2001-08-24 AU AU2001284317A patent/AU2001284317A1/en not_active Abandoned
- 2001-08-24 CA CA002420327A patent/CA2420327A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001284317A1 (en) | 2002-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080311591A1 (en) | Differential Immunoassay | |
| JP2628421B2 (ja) | 診断試験用キットおよびこれを用いる方法 | |
| US5914241A (en) | Assays and kits for detecting analytes in the presence of cross-reacting substances | |
| US5744358A (en) | Method and device for diagnosing and distinguishing chest pain in early onset thereof | |
| US5710008A (en) | Method and device for diagnosing and distinguishing chest pain in early onset thereof | |
| JP3197277B2 (ja) | 一種類以上の免疫学的配位子の分析方法，その分析試薬およびそのキット | |
| CA2201153C (fr) | Anticorps monoclonal contre la myoglobine cardiaque humaine | |
| EP1301790B1 (fr) | Evaluation directe de rapports analyte/molecule de reference | |
| EP0249418A2 (fr) | Essai immunologique pour dosage d'immunoglobuline avec un procédé de contrôle intégré | |
| JP4197393B2 (ja) | ＩｇＡ腎症の検査法 | |
| CN112166323A (zh) | 自身抗体的直接免疫测定测量 | |
| EP1947459A2 (fr) | Dosage immunologique différentiel | |
| CA2420327A1 (fr) | Dosage immunologique differentiel | |
| US5436132A (en) | Quantitative determination of tenascin as glioma marker | |
| EP1371986A1 (fr) | Diagnostic de la maladie d'Alzheimer basé sur le rapport entre hAbèta42 et hAbèta40 | |
| JP4273311B2 (ja) | 試料中の測定対象物質の測定方法及び測定試薬 | |
| JP2000193662A (ja) | 尿中シスタチンｃ測定試薬及び診断方法並びにキット | |
| US20110014638A1 (en) | Soluble fas in acute coronary syndromes diagnosis | |
| WO2009005968A1 (fr) | Dosages pour détecter des anticorps pour des agents thérapeutiques | |
| JPH0989892A (ja) | 付着性抗原の測定方法 | |
| WO2002008722A2 (fr) | Evaluation directe de concentrations relatives de variants d'un epitope sur une molecule dimere |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |